Strong Patent Foundation

Onselex has established a broad intellectual property portfolio around its nanoparticle technology and continues to expand its patent coverage across nanoparticle oncology therapeutics and potential applications for various difficult-to-treat diseases. Onselex currently holds granted patents in Japan, the European Union, the United Kingdom, South Korea, the United States, and Canada.